Global Quadrivalent Market

Global Quadrivalent Market Opportunities And Strategies 2023

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s quadrivalent market report forecasts the quadrivalent market size to grow to $10.58 Billion by 2027, with a CAGR (compound annual growth rate) of more than 7%.

Learn More On The Quadrivalent Market Report 2023 –

Quadrivalent Market Size Forecast
The global quadrivalent market is expected to grow from $7.30 billion in 2022 to $7.87 billion in 2023 at a compound annual growth rate (CAGR) of 7.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global quadrivalent market size is expected to grow to $10.58 billion in 2027 at a CAGR of 7.7%.

North America held the largest quadrivalent market share.

Key Quadrivalent Market Driver ­– Rise In The Prevalence Of Chronic And Infectious Diseases
According to the World Health Organisation, a Switzerland-based institution responsible for international public health, 17 million people would die from a chronic or noncommunicable disease (NCD) before the age of 70 in September 2022. Furthermore, there are expected to be 247 million instances of malaria (an infectious disease) worldwide in 2021, with an estimated 619,000 deaths. As a result, the increased prevalence of chronic and infectious diseases is propelling the quadrivalent market forward.

Request for A Sample Of The Global Quadrivalent Market Report:

Key Quadrivalent Market Trend – Product Innovations
Major players in the quadrivalent market are focusing on producing unique solutions to increase their market position. For example, AstraZeneca, a UK-based pharmaceutical company, will launch FluMist quadrivalent (Influenza Vaccination Live, Intranasal), a Food and Drug Administration (FDA)-approved nasal-spray flu vaccine for people aged 2 to 49, in September 2022. It is a live attenuated influenza vaccine (LAIV) that is available in trivalent or quadrivalent formulations and is covered by the majority of health insurance policies as well as the vaccinations for children programme.

Quadrivalent Market Segment
1) By Type: Intradermal Shot, Intramuscular Injection, Nasal Spray
2) By Technology: Conjugated, Live, Inactivated, Recombinant, Toxoid, Other Technologies
3) By Disease: Cancer, Hepatitis, Pneumococcal disease, COVID-19, Influenza, Human Papilloma Virus, Meningococcal Disease, Polio, Rotavirus, Other Diseases
4) By Age Group: Pediatric, Adult
5) By Distribution Channel: Hospital And Pharmacy, Government Suppliers, Other Channels (NGOs)

Quadrivalent Market Major Players and Strategies
Major players in the quadrivalent market are AstraZeneca Plc., Serum Institute of India Pvt. Ltd., Sanofi S.A., GlaxoSmithKline Plc., CSL Limited, Bharat Biotech International Ltd., Hualan Biological Engineering Inc., Merck & Co. Inc., Johnson & Johnson SA, Novartis AG, Pfizer Inc., Xenetic Biosciences Inc., Bio Med Pvt. Ltd., Walvax Biotechnology Co. Ltd., and Chongqing Zhifei Biological Products Co. Ltd.

Merck & Co. Inc., a US-based pharmaceutical corporation, finalised the acquisition of Themis Bioscience Gmbh in June 2020 for an undisclosed sum. This acquisition aims to accelerate the development of a SARS-CoV-2 vaccine candidate based on a measles vector. Themis Bioscience GmbH is a biotechnology start-up established in Austria that creates vaccinations to combat infectious diseases.

The Quadrivalent Global Market Report 2023 covers regional data on quadrivalent market size, quadrivalent market trends and drivers, opportunities, strategies, and quadrivalent market competitor analysis. The countries covered in the quadrivalent market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

A quadrivalent vaccine induces the immune system to respond to diverse antigens, such as four different viruses or bacteria. A quadrivalent vaccination is designed to protect against four different flu viruses, two of which are type A and two of which are type B.

View More Reports Related To The Quadrivalent Market –
Ventricular Assist Device Global Market Report 2023
Network Engineering Services Global Market Report 2023
Product Engineering Services Global Market Report 2023

Contact us at:
The Business Research Company:
+1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
Global Market Model:
Found this article helpful? Share it on: